Skip to Content Skip to Search


Prescription medicines


Product information:

RELENZA product monograph (PDF - 669 KB)

Health-care Professional Information:

November 3, 2009 - Notice to Hospitals - Health Canada Endorsed Important Safety Information (PDF - 30.3 KB) on PrRELENZA (zanamivir) Dry Powder for Inhalation

Consumer Information:

“Please read the “Consumer Information” leaflet for RELENZA located on this website as it contains important safety information on RELENZA.”
Information (PDF - 669 KB)